Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Research Support, Non-U.S. Gov't"
topic_facet:"Antibodies, Monoclonal, Humanized"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%221468-2060%22&type=ISN
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%221468-2060%22&type=ISN
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%221468-2060%22&type=ISN
PubPharm (292)
1
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Taylor, P.
|
Weinblatt, M.
|
McInnes, I.
| +18
Wird geladen...
2
Response to : 'Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial'' by Zhao and Huang
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Wei, J.
|
Kim, T.
|
Kishimoto, M.
| +3
CommentOn: Ann Rheum Dis. 2021 Aug;80(8):1014-1021. - PMID 33827787
Wird geladen...
3
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Morand, E.
|
Abreu, G.
|
Furie, R.
| +2
ErratumIn: Ann Rheum Dis. 2024 Mar 15;:. - PMID 38490730
Wird geladen...
4
Correspondence on : 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Cheng, C.
|
Zhang, F.
CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597
Wird geladen...
5
Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Pethoe-Schramm, A.
|
Devenport, J.
|
Reiss, W.
CommentOn: Ann Rheum Dis. 2020 Jul;79(7):874-882. - PMID 32371387
Wird geladen...
6
Safety of ixekizumab in patients with psoriatic arthritis : data from four clinical trials with over 2000 patient-years of exposure
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Deodhar, A.
|
Combe, B.
|
Accioly, A.
| +5
Wird geladen...
7
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE : post hoc analysis of pooled data from two phase III trials
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Vital, E.
|
Merrill, J.
|
Morand, E.
| +9
Wird geladen...
8
Concordance and discordance in SLE clinical trial outcome measures : analysis of three anifrolumab phase 2/3 trials
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Bruce, I.
|
Furie, R.
|
Morand, E.
| +10
Wird geladen...
9
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE) : a phase 2/3 randomised controlled trial
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Bonelli, M.
|
Radner, H.
|
Kerschbaumer, A.
| +8
Wird geladen...
10
Obinutuzumab in connective tissue diseases after former rituximab-non-response : a case series
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Kvacskay, P.
|
Merkt, W.
|
Günther, J.
| +2
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Filter aufheben
Thema: Antibodies, Monoclonal, Humanized
Medienart
292
Aufsätze
273
E-Artikel
273
E-Ressourcen
19
Gedruckte Aufsätze
Zeitschriftentitel
292
Annals of the rheumatic diseases
Thema
Antibodies, Monoclonal, Humanized
Research Support, Non-U.S. Gov't
261
Journal Article
202
Antirheumatic Agents
132
Antibodies, Monoclonal
132
Randomized Controlled Trial
126
Adalimumab
126
FYS6T7F842
101
Multicenter Study
97
Tumor Necrosis Factor-alpha
75
Methotrexate
74
YL5FZ2Y5U1
65
I031V2H011
65
tocilizumab
60
Clinical Trial, Phase III
56
B72HH48FLU
56
Infliximab
52
Etanercept
52
Immunoglobulin G
52
OP401G7OJC
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
50
2020-
196
2010-2019
46
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
292
Englisch
Haven't found what you're looking for?
Wird geladen...